Advancements in the research of the structure, function, and disease-related roles of ARMC5.
10.1007/s11684-024-1108-0
- Author:
Yang QU
1
;
Fan YANG
2
;
Yafang DENG
3
;
Haitao LI
4
;
Yidong ZHOU
5
,
6
;
Xuebin ZHANG
6
,
7
Author Information
1. Department of Breast Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
2. Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
3. State Key Laboratory of Molecular Oncology, Beijing Frontier Research Center for Biological Structure, School of Basic Medical Sciences, Tsinghua University, Beijing, 100084, China.
4. State Key Laboratory of Molecular Oncology, Beijing Frontier Research Center for Biological Structure, School of Basic Medical Sciences, Tsinghua University, Beijing, 100084, China. lht@tsinghua.edu.cn.
5. Department of Breast Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China. zhouydpumch@
6. com.
7. Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China. xuebinzh@
- Publication Type:Review
- Keywords:
ARMC5 gene;
BMAD;
meningioma;
primary aldosteronism;
renal cell carcinoma
- MeSH:
Humans;
Neoplasms/genetics*;
Armadillo Domain Proteins/genetics*;
Animals;
Genetic Predisposition to Disease;
Cytoskeletal Proteins/genetics*;
Tumor Suppressor Proteins/genetics*
- From:
Frontiers of Medicine
2025;19(2):185-199
- CountryChina
- Language:English
-
Abstract:
The armadillo repeat containing 5 (ARMC5) gene is part of a family of protein-coding genes that are rich in armadillo repeat sequences, are ubiquitously present in eukaryotes, and mediate interactions between proteins, playing roles in various cellular processes. Current research has demonstrated that reduced expression or absence of the ARMC5 gene in various tumor tissues can lead to uncontrolled cell proliferation, thereby inducing a range of diseases. The ARMC5 gene was initially extensively studied in the context of bilateral macronodular adrenocortical disease (BMAD), with harmful pathogenic variants in ARMC5 identified in approximately 50% of BMAD patients. With advancing research, scientists have discovered that ARMC5 pathogenic variants may also have potential effects on other diseases and could be associated with increased susceptibility to certain cancers. This review aims to present the latest research progress on how the ARMC5 gene plays its role in tumors. It outlines the basic structure of ARMC5 and the regions where it functions, as well as the diseases currently proven to be associated with ARMC5. Moreover, some evidence suggests its relation to embryonic development and the regulation of immune system activity. In conclusion, the ARMC5 gene is a crucial focal point in genetic and medical research. Understanding its function and regulation is of great importance for the development of new therapeutic strategies related to diseases associated with its pathogenic variants.
